Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738345 · ClinicalTrials.gov registry record · NA
The Effects of Flow Settings During High Flow Nasal Cannula for Adult Hypoxemia Patients
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03738345 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT03738345, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
High flow nasal cannula (HFNC) delivers oxygen at a flow which exceeds the patient's inspiratory flow demand in order to improve oxygenation. Numerous randomized control trials and meta-analyses have shown that HFNC improves oxygenation and helps avoid intubation in hypoxemic patients, as well as reduce work of breathing, improve ventilation, and decrease hypercapnia in COPD patients. Flow settings play a critical role when using HFNC, as increased flow can reduce inspiratory effort, improve ventilation, and dynamic lung compliance. However, flow rates used in many studies vary widely. The clinical effects of different HFNC flow setting, specifically to match or over than a patients' own inspiratory flow, is still unknown.
Interventions
- OTHER HFNC flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2018-12-26 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03738345
The ClinicalTrials.gov registry entry for NCT03738345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HFNC flow is the first listed.
NCT03738345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03738345 about?
NCT03738345 is a clinical study titled "The Effects of Flow Settings During High Flow Nasal Cannula for Adult Hypoxemia Patients". High flow nasal cannula (HFNC) delivers oxygen at a flow which exceeds the patient's inspiratory flow demand in order to improve oxygenation. Numerous randomized control trials and meta-analyses have shown that HFNC improves oxygenation and helps avoid intubation in hypoxemic patients, as well as re...
What is the current status of trial NCT03738345?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2018-12-26. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03738345?
The interventions under investigation include: HFNC flow (OTHER).
Who is sponsoring clinical trial NCT03738345?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.